Strand Life integrates ChemAxon suite

Strand Life Sciences, the informatics company spun-off by Indian Institute of Science's (IISc), has integrated ChemAxon's JChem suite of software for chemical analysis with Strand's Admetis.

Strand's Admetis is a comprehensive platform for modelling and predicting drug-relevant properties of molecules in silico, a company release said.

According to Kas Subramanian, chief scientific officer, Strand Life Sciences, "The integrated offering is expected to be launched early in the first quarter of 2006. The company's Admetis couples pre-built models with a workflow-based modelling platform, making it a distinct offering."

"Some of the key features of JChem directly address requests from our prospects and customers. The tool also gives users the power to build custom models using their own data. We believe that the integration will benefit customers," he added.

The inclusion of ChemAxon's JChem toolkit provides Admetis with a feature-rich, chemically aware data management and search framework. Admetis users will be able to enjoy state-of-the-art chemical editing and visualisation capabilities as well as the power to build complex queries using structural and non-structural data.

"We are happy, we have a good fit with the Admetis offering and given Strands expertise and ambitious plans for future development we see a bright future for the collaboration," said Ferenc Csizmadia, CEO of ChemAxon.

The tool from ChemAxon has been devised through easy and intuitive model-building workflows based on Strand's expertise in 'in silico' model building.

Admetis has an extensive data mining and visualisation module that supports an embedded chemical structure viewer.